Page last updated: 2024-10-27

gabexate and Reperfusion Injury

gabexate has been researched along with Reperfusion Injury in 14 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research Excerpts

ExcerptRelevanceReference
"To investigate whether gabexate mesilate, a synthetic protease inhibitor with anticoagulant properties, prevents hepatic damage by inhibiting leukocyte activation, we examined its effect on ischemia/reperfusion injury of rat liver in which activated leukocytes play a critical role."7.70Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation. ( Harada, N; Kushimoto, S; Okajima, K, 1999)
"To assess the effects of gabexate mesilate (FOY), a protease inhibitor, on a canine model of pulmonary ischemia-reperfusion injury."7.70Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs. ( Chen, JS; Kuo, SH; Lee, YC; Lin-Shiau, SY; Luh, SP; Shau, WY; Tsai, CC, 1999)
"To investigate whether gabexate mesilate, a synthetic protease inhibitor with anticoagulant properties, prevents hepatic damage by inhibiting leukocyte activation, we examined its effect on ischemia/reperfusion injury of rat liver in which activated leukocytes play a critical role."3.70Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation. ( Harada, N; Kushimoto, S; Okajima, K, 1999)
"To assess the effects of gabexate mesilate (FOY), a protease inhibitor, on a canine model of pulmonary ischemia-reperfusion injury."3.70Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs. ( Chen, JS; Kuo, SH; Lee, YC; Lin-Shiau, SY; Luh, SP; Shau, WY; Tsai, CC, 1999)
" GM was administered intravenously at a dosage of 2."2.72Evaluation of a protease inhibitor in the prevention of ischemia and reperfusion injury in hepatectomy under intermittent Pringle maneuver. ( Chun, BY; Chung, HJ; Hwang, YJ; Kim, YI; Lee, JW; Lee, YJ; Song, KE, 2006)
"Gabexate mesilate pretreatment abrogated the positive correlation between postreperfusion hepatocyte injury and hepatic ischemia time."2.70Hepatocyte protection by a protease inhibitor against ischemia/reperfusion injury of human liver. ( Chun, BY; Hwang, YJ; Kim, YI; Lee, JW; Song, KE; Yun, YK, 2002)
"The roles of TNFalpha and IL-6 in liver reperfusion injury were not clear, though TNFalpha might have had an effect during the early phase."1.30Effect of protease inhibitor on ischemia-reperfusion injury to rat liver. ( Choe, KJ; Ha, J; Jung, SE; Kim, SJ; Lee, JE; Noh, DY; Oh, SK; Youn, YK; Yun, IJ, 1999)
"Reperfusion injury is a large problem in the early stage after lung transplantation."1.29The effect of protease inhibitor on reperfusion injury after unilateral pulmonary ischemia. ( Harada, Y; Horiguchi, T, 1993)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.14)18.7374
1990's6 (42.86)18.2507
2000's7 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, YI2
Hwang, YJ2
Song, KE2
Yun, YK1
Lee, JW2
Chun, BY2
Fitzal, F1
DeLano, FA1
Young, C1
Schmid-Schönbein, GW1
Inoue, S1
Sugitani, A1
Yamamoto, H1
Kitada, H1
Motoyama, K1
Okabe, Y1
Ohta, M1
Yoshida, J1
Nishiyama, K1
Tanaka, M1
Chung, HJ1
Lee, YJ1
Gezici, A1
Ozturk, H2
Buyukbayram, H1
Okur, H1
Chen, CF1
Wang, D1
Lin, HI1
Shen, CY1
Yang, NP1
Horiguchi, T1
Harada, Y1
Hossain, MA1
Hamamoto, I1
Okano, K1
Okada, S1
Wakabayashi, H1
Maeba, T1
Maeta, H1
Harada, N1
Okajima, K1
Kushimoto, S1
Zimmerman, JJ1
Jung, SE1
Yun, IJ1
Youn, YK1
Lee, JE1
Ha, J1
Noh, DY1
Kim, SJ1
Oh, SK1
Choe, KJ1
Luh, SP2
Tsai, CC2
Shau, WY2
Chen, JS1
Kuo, SH2
Lin-Shiau, SY1
Lee, YC1
Shiau, SY1
Jan, IS1
Yang, PC1
Sasaki, S1

Trials

2 trials available for gabexate and Reperfusion Injury

ArticleYear
Hepatocyte protection by a protease inhibitor against ischemia/reperfusion injury of human liver.
    Journal of the American College of Surgeons, 2002, Volume: 195, Issue:1

    Topics: Adult; Aged; Case-Control Studies; Female; Gabexate; Hepatectomy; Humans; Interleukin-6; Liver; Male

2002
Evaluation of a protease inhibitor in the prevention of ischemia and reperfusion injury in hepatectomy under intermittent Pringle maneuver.
    American journal of surgery, 2006, Volume: 191, Issue:1

    Topics: Adult; Female; Gabexate; Hepatectomy; Humans; Ischemia; Liver; Liver Diseases; Male; Middle Aged; Pr

2006

Other Studies

12 other studies available for gabexate and Reperfusion Injury

ArticleYear
Early capillary no-reflow during low-flow reperfusion after hind limb ischemia in the rat.
    Annals of plastic surgery, 2002, Volume: 49, Issue:2

    Topics: Animals; Capillary Resistance; Endothelium, Vascular; Erythrocytes; Femoral Artery; Fluorescent Dyes

2002
Effect of synthetic protease inhibitor gabexate mesilate on the attenuation of ischemia/reperfusion injury in canine kidney autotransplantation.
    Surgery, 2005, Volume: 137, Issue:2

    Topics: Animals; Blood Urea Nitrogen; Creatinine; Cytokines; Dogs; Gabexate; Gene Expression; Kidney; Kidney

2005
Effects of gabexate mesilate on ischemia-reperfusion-induced testicular injury in rats.
    Pediatric surgery international, 2006, Volume: 22, Issue:5

    Topics: Animals; Gabexate; Lipid Peroxidation; Male; Microcirculation; Radionuclide Imaging; Random Allocati

2006
Translocation of pancreatic juice after ischemia and reperfusion of the intestines and the effects of gabexate mesilate (FOY) in rats.
    Transplantation proceedings, 2007, Volume: 39, Issue:4

    Topics: Animals; Disease Models, Animal; Gabexate; Intestines; Male; Mesenteric Artery, Superior; Pancreatic

2007
The effect of protease inhibitor on reperfusion injury after unilateral pulmonary ischemia.
    Transplantation, 1993, Volume: 55, Issue:2

    Topics: Animals; Dogs; Free Radical Scavengers; Gabexate; Glycoproteins; Ischemia; Lung; Neutrophils; Radiog

1993
Ameliorative effect of gabexate mesilate on the disturbed microcirculation following prolonged cold ischemia of the liver.
    Transplantation proceedings, 1996, Volume: 28, Issue:1

    Topics: Adenosine; Allopurinol; Analysis of Variance; Animals; Anticoagulants; Bile; Cold Temperature; Gabex

1996
Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation.
    Critical care medicine, 1999, Volume: 27, Issue:9

    Topics: Analysis of Variance; Animals; Gabexate; Interleukin-8; Leukocytes; Liver; Liver Circulation; Liver

1999
What's the buzz (on protease inhibitors)...tell me what's (mechanistically) happening.
    Critical care medicine, 1999, Volume: 27, Issue:9

    Topics: Animals; Gabexate; Humans; Interleukin-8; Liver Circulation; Neutrophils; Rats; Reperfusion Injury;

1999
Effect of protease inhibitor on ischemia-reperfusion injury to rat liver.
    World journal of surgery, 1999, Volume: 23, Issue:10

    Topics: Animals; Catalase; Disease Models, Animal; Female; Gabexate; Interleukin-6; Lipid Peroxidation; Live

1999
Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs.
    The Journal of surgical research, 1999, Volume: 87, Issue:2

    Topics: Animals; Bronchoalveolar Lavage Fluid; Dogs; Gabexate; Hemodynamics; Ischemia; Lung; Neutrophils; Pe

1999
Protective effects of inhaled nitric oxide and gabexate mesilate in lung reperfusion injury after transplantation from non-heart-beat donors.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2002, Volume: 21, Issue:2

    Topics: Administration, Inhalation; Animals; Blood Gas Analysis; Bronchoalveolar Lavage Fluid; Capillary Per

2002
[Experimental study on renal protection against damage in kidneys subjected warm ischemia--protective effect of FOY, SOD, and PEG-SOD on ischemic acute renal failure].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1989, Volume: 64, Issue:4

    Topics: Acute Kidney Injury; Animals; Gabexate; Guanidines; Ischemia; Kidney; Kidney Tubules; Necrosis; Poly

1989